Bristol-Myers Squibb has a total of 29200 patents globally, out of which 12363 have been granted. Of these 29200 patents, more than 59% patents are active. United States of America is where Bristol-Myers Squibb has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Bristol-Myers Squibb.
Bristol-Myers Squibb was founded in the year 1989. The Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol Myers Squibb focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
Do read about some of the most popular patents of Bristol-Myers Squibb which have been covered by us in this article and also you can find Bristol-Myers Squibb patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Bristol-Myers Squibb patent portfolio.
How many patents does Bristol-Myers Squibb have?
Bristol-Myers Squibb has a total of 29200 patents globally. These patents belong to 8774 unique patent families. Out of 29200 patents, 17269 patents are active.
How Many Patents did Bristol-Myers Squibb File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Bristol-Myers Squibb Applications Filed | Bristol-Myers Squibb Patents Granted |
| 2025 | 33 | 131 |
| 2024 | 269 | 549 |
| 2023 | 571 | 582 |
| 2022 | 917 | 565 |
| 2021 | 1041 | 630 |
| 2020 | 1135 | 656 |
| 2019 | 1387 | 573 |
| 2018 | 1628 | 564 |
| 2017 | 1506 | 646 |
| 2016 | 1375 | 501 |
| 2015 | 1612 | 483 |
How many Bristol-Myers Squibb patents are Alive/Dead?
Worldwide Patents
How Many Patents did Bristol-Myers Squibb File in Different Countries?
Countries in which Bristol-Myers Squibb Filed Patents
| Country | Patents |
| United States of America | 4493 |
| Europe (EPO) | 2584 |
| Japan | 2011 |
| China | 1307 |
| Korea (South) | 1299 |
| Israel | 1120 |
| India | 1022 |
| Australia | 955 |
| Canada | 952 |
| Spain | 925 |
| Singapore | 808 |
| Brazil | 694 |
| Taiwan | 639 |
| Mexico | 594 |
| South Africa | 582 |
| Hong Kong (S.A.R.) | 575 |
| Argentina | 509 |
| Austria | 409 |
| Germany | 362 |
| Hungary | 362 |
| Eurasia | 360 |
| Denmark | 357 |
| Poland | 353 |
| Malaysia | 325 |
| Portugal | 290 |
| Turkey | 257 |
| Norway | 229 |
| Croatia | 223 |
| Slovenia | 219 |
| New Zealand | 200 |
| Colombia | 191 |
| Thailand | 165 |
| Serbia | 162 |
| Viet Nam | 147 |
| Russia | 133 |
| Lithuania | 121 |
| Philippines | 99 |
| Uruguay | 97 |
| Morocco | 82 |
| Ireland | 78 |
| Indonesia | 78 |
| Tunisia | 69 |
| Gulf Cooperation Council | 64 |
| Ukraine | 51 |
| Macao | 49 |
| Latvia | 47 |
| Republic of Moldova | 41 |
| Bulgaria | 40 |
| Georgia | 39 |
| Iceland | 35 |
| United Kingdom | 32 |
| Czech Republic | 32 |
| Finland | 31 |
| Saudi Arabia | 21 |
| Slovakia | 20 |
| Estonia | 19 |
| Romania | 18 |
| France | 10 |
| Netherlands | 7 |
| Costa Rica | 7 |
| Luxembourg | 6 |
| Africa | 5 |
| Italy | 2 |
| Belgium | 2 |
| Ecuador | 1 |
| Switzerland | 1 |
Where are Research Centres of Bristol-Myers Squibb Patents Located?
10 Best Bristol-Myers Squibb Patents
WO2014008218A1 is the most popular patent in the Bristol-Myers Squibb portfolio. It has received 1092 citations so far from companies like Pharmacyclics Inc, Mersana Therapeutics and Iovance Biotherapeutics.
Below is the list of 10 most cited patents of Bristol-Myers Squibb:
| Publication Number | Citation Count |
| WO2014008218A1 | 1092 |
| WO2013173223A1 | 1006 |
| WO2015034820A1 | 575 |
| US20080139791A1 | 444 |
| US7288638B2 | 423 |
| US20080260738A1 | 379 |
| WO2014151634A1 | 378 |
| WO2006020082A1 | 357 |
| WO2005092899A1 | 355 |
| US7960515B2 | 333 |
What Percentage of Bristol-Myers Squibb US Patent Applications were Granted?
Bristol-Myers Squibb (Excluding its subsidiaries) has filed 9797 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6766 have been granted leading to a grant rate of 83.99%.
Below are the key stats of Bristol-Myers Squibb patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Bristol-Myers Squibb?
| Law Firm | Total Applications | Success Rate |
| Henry Hadad | 3367 | 74.73% |
| Sterne Kessler Goldstein & Fox PLLC | 271 | 67.84% |
| David M Morse | 223 | 66.20% |
| Burton Rodney | 209 | 74.60% |
| Glaxosmithkline | 156 | 68.63% |
| Nelson Mullins Riley & Scarborough Llp | 154 | 48.58% |
| Bristol Myers Squibb (Inhouse Ip Dept.) | 139 | 62.74% |
| Convatec Technologies | 117 | 69.70% |
| Wolf Greenfield & Sacks PC | 88 | 81.18% |
| Todd A Dawson | 73 | 97.26% |
What are Bristol-Myers Squibb key innovation segments?
What Technologies are Covered by Bristol-Myers Squibb?
The chart below distributes patents filed by Bristol-Myers Squibb in different countries on the basis of the technology protected in patents. It also represents the markets where Bristol-Myers Squibb thinks it’s important to protect particular technology inventions.
R&D Focus: How has Bristol-Myers Squibb search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Bristol-Myers Squibb?
